This inventor holds 2 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignee: Oslo Universitetssykehus Hf. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Inventor Sébastien Wälchli
Introduction
Sébastien Wälchli is an accomplished inventor based in Oslo, Norway. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 2 patents, his work focuses on developing innovative solutions that enhance personalized medicine.
Latest Patents
Wälchli's latest patents include groundbreaking inventions aimed at improving cancer therapies. One of his notable patents is for specific binding molecules for hTERT. This invention provides a nucleic acid molecule that encodes a specific binding molecule capable of binding an hTERT peptide when presented by a Class II Major Histocompatibility Complex (MHC). The specific binding molecule comprises a first polypeptide with a variable region of an α-chain and a second polypeptide with a variable region of a β-chain of a T-cell receptor (TCR). This invention has significant utility in cancer treatment.
Another important patent by Wälchli is related to universal killer T-cells. This invention involves modified natural killer (NK) cells that are non-immunogenic, allowing them to be administered to any recipient without rejection by the host immune system. These modified NK cells can express CD3 and a T-cell Receptor (TcR), enabling them to show antigen-specific cytotoxicity towards target cells. This innovation holds promise for personalized medicine, especially in oncology.
Career Highlights
Sébastien Wälchli is currently associated with Oslo Universitetssykehus HF, where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential impact on cancer therapies.
Collaborations
Wälchli collaborates with esteemed colleagues such as Gunnar Kvalheim and Gustav Gaudernack. Their combined expertise contributes to the development of cutting-edge solutions in the field of biotechnology.
Conclusion
Sébastien Wälchli is a notable inventor whose work in biotechnology is paving the way for advancements in cancer treatment. His innovative patents reflect a commitment to improving personalized medicine and enhancing patient outcomes.